Ellen N. Spremulli

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Heterogeneity of cancer cells from a single human colon carcinoma

Daniel L. Dexter, Ellen N. Spremulli, Zuzana Fligiel et al. · The American Journal of Medicine · 1981 · 167 citations

Medicine, Cancer Biology, Oncology +14

Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein

David M. Goldenberg, E. Edmund, Frank H. DeLand et al. · Cancer · 1980 · 124 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Implementation and Impact of Patient Lay Navigator-Led Advance Care Planning Conversations

Gabrielle B. Rocque, J. Nicholas Dionne‐Odom, Chao‐Hui Huang et al. · Journal of Pain and Symptom Management · 2017 · 111 citations · Full text

Social Sciences, Family Medicine, Health Communication +7

Axillary lymphoscintigraphy by radioimmunodetection of carcinoembryonic antigen in breast cancer.

Kim Ee, Corgan Rl, Scott E. Casper et al. · PubMed · 1979 · 63 citations

Medicine, Nuclear Medicine, Oncology +17